Mumbai, India

Yusuf Khwaja Hamied

This inventor holds 7 USPTO granted patents, plus 1 CIPO patent. Top assignees: Cipla Limited, U & I Pharmaceuticals, Ltd.. Active years: 2002-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yusuf Khwaja Hamied. Retrieved from https://idiyas.com/inventor/yusuf-khwaja-hamied

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 57.1


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 66(Granted Patents)


Location History:

  • Mumbai, IN (2002 - 2006)
  • Mah, IN (2006)
  • Bombay, IN (2006 - 2013)

Company Filing History:


Years Active: 2002-2013

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Yusuf Khwaja Hamied - The Innovative Mind from Mumbai

Introduction: Yusuf Khwaja Hamied, a prominent inventor hailing from Mumbai, India, is known for his groundbreaking contributions to the field of pharmaceuticals.

Latest Patents: Yusuf Khwaja Hamied holds several patents in the pharmaceutical industry, with his most recent inventions focusing on novel drug delivery systems and formulations for various diseases.

Career Highlights: Throughout his illustrious career, Yusuf Khwaja Hamied has led research and development teams, spearheading the creation of life-saving medications that have positively impacted countless lives globally.

Collaborations: Yusuf Khwaja Hamied has collaborated with leading research institutions, universities, and pharmaceutical companies to further advance the field of medicine and bring innovative solutions to the market.

Conclusion: In conclusion, Yusuf Khwaja Hamied's dedication to innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…